| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2017/2193432 |
| P8608 | Fatcat ID | release_p76d6mhmqzhqvj5oznhj5lxvbm |
| P932 | PMC publication ID | 5576438 |
| P698 | PubMed publication ID | 28900446 |
| P2093 | author name string | Lin Chen | |
| Shaohua Liao | |||
| Suxia Wang | |||
| Bingzhen Cao | |||
| Zhenhua Zhou | |||
| Chunxia Luo | |||
| Huaiqiang Hu | |||
| Huili Yue | |||
| P2860 | cites work | Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes | Q44361044 |
| Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling | Q44403591 | ||
| Aging, progenitor cell exhaustion, and atherosclerosis | Q44513172 | ||
| Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent | Q44941164 | ||
| Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume | Q45025359 | ||
| Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats | Q45048601 | ||
| Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells | Q45874341 | ||
| Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: A potential role for G-CSF. | Q45907263 | ||
| Development of transgenic endothelial progenitor cell-seeded stents | Q47252484 | ||
| Precision nanomedicine in neurodegenerative diseases | Q47572373 | ||
| Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke | Q47599310 | ||
| Evidence for circulating bone marrow-derived endothelial cells. | Q47612637 | ||
| Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization | Q47998965 | ||
| Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke | Q48175406 | ||
| Challenging the great vascular wall: Can we envision a simple yet comprehensive therapy for stroke? | Q48316365 | ||
| Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible Mechanism | Q48651195 | ||
| Intravenous autologous bone marrow mononuclear cells for ischemic stroke | Q49015926 | ||
| Improving stem cell mobilization strategies: future directions | Q37367235 | ||
| The regulatory role of NF-κB in autophagy-like cell death after focal cerebral ischemia in mice | Q37562252 | ||
| Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy | Q38046191 | ||
| Neural stem cells and stroke | Q38057868 | ||
| Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection | Q38097282 | ||
| Preconditioning strategy in stem cell transplantation therapy | Q38126494 | ||
| Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury | Q38151419 | ||
| Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies | Q38202978 | ||
| Accelerating in situ endothelialisation of cardiovascular bypass grafts. | Q38304670 | ||
| Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supp | Q38418091 | ||
| Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer. | Q38425798 | ||
| Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke | Q38469989 | ||
| Promoting recovery from ischemic stroke | Q38675024 | ||
| Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke | Q38742380 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Expression of cytokines in rat brain with focal cerebral ischemia after grafting with bone marrow stromal cells and endothelial progenitor cells | Q39663957 | ||
| Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia | Q40366934 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Impaired vascular remodeling after endothelial progenitor cell transplantation in MMP9-deficient mice suffering cortical cerebral ischemia | Q40685439 | ||
| The neurovascular unit in health and disease: introduction | Q41884816 | ||
| A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature | Q41968950 | ||
| Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease | Q42485863 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. | Q42579727 | ||
| Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain | Q42652739 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels | Q42816285 | ||
| One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent | Q42849806 | ||
| Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha | Q42971426 | ||
| Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease | Q43013602 | ||
| Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction | Q43042585 | ||
| Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction | Q43055690 | ||
| Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability | Q43186547 | ||
| Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. | Q43491607 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease | Q43645304 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. | Q43890690 | ||
| Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization | Q44281968 | ||
| Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 | ||
| Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 | ||
| Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization | Q24673319 | ||
| Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy | Q26823609 | ||
| Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice | Q27324791 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog | Q30406999 | ||
| Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. | Q31113573 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells | Q33187089 | ||
| Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization | Q33481414 | ||
| Endothelial progenitor cells: therapeutic perspective for ischemic stroke | Q33705402 | ||
| Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study | Q33748370 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 | ||
| Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain | Q33982602 | ||
| The use of magnetic resonance cell tracking to monitor endothelial progenitor cells in a rat hindlimb ischemic model | Q34113993 | ||
| A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro | Q34121606 | ||
| Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. | Q34228118 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions | Q34310812 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Endothelial progenitor cells correlate with lesion volume and growth in acute stroke | Q34370888 | ||
| How do stem cells find their way home? | Q34418463 | ||
| Nanoparticle technology for drug delivery across the blood-brain barrier | Q34540557 | ||
| Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry | Q34590096 | ||
| Endothelial progenitor cells for vascular regeneration | Q34619706 | ||
| Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. | Q34632614 | ||
| Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells | Q34843244 | ||
| Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice | Q34984321 | ||
| Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells | Q35055700 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Post-natal endothelial progenitor cells for neovascularization in tissue regeneration | Q35131758 | ||
| The secretome of endothelial progenitor cells promotes brain endothelial cell activity through PI3-kinase and MAP-kinase | Q35154977 | ||
| Circulating endothelial progenitor cells and the risk of vascular events after ischemic stroke | Q35390385 | ||
| Lost in translation: taking neuroprotection from animal models to clinical trials. | Q35832807 | ||
| Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice | Q35912793 | ||
| Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators | Q35993096 | ||
| Endothelial progenitor cells in atherosclerosis | Q36011477 | ||
| Cell therapy for stroke | Q36045372 | ||
| Interactions of platelets with subendothelium and endothelium | Q36090987 | ||
| Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization | Q36227849 | ||
| Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo | Q36238074 | ||
| The impact of progenitor cells in atherosclerosis | Q36381967 | ||
| Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells | Q36402579 | ||
| Endothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathway | Q36537288 | ||
| Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential | Q36562163 | ||
| The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients | Q36643126 | ||
| Neurogenic potential of engineered mesenchymal stem cells overexpressing VEGF | Q36795036 | ||
| Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis. | Q36814937 | ||
| Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials | Q36851576 | ||
| Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro | Q36968176 | ||
| Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells | Q36974148 | ||
| Endothelial progenitor cells in neovascularization of infarcted myocardium | Q37066764 | ||
| Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair | Q37199481 | ||
| Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. | Q37320339 | ||
| Effect of onion peel extract on endothelial function and endothelial progenitor cells in overweight and obese individuals | Q50438986 | ||
| Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. | Q50865906 | ||
| Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype. | Q51022148 | ||
| A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. | Q51207735 | ||
| Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: synergistic effect on angiogenesis in mouse ischemic limbs. | Q51216991 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. | Q51618016 | ||
| Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. | Q51623611 | ||
| Human endothelial progenitor cells-derived exosomes accelerate cutaneous wound healing in diabetic rats by promoting endothelial function. | Q53092582 | ||
| Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial. | Q53171431 | ||
| Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction. | Q53355002 | ||
| bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells | Q54640761 | ||
| Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. | Q54693974 | ||
| Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction | Q57589498 | ||
| Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function | Q58230259 | ||
| High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells | Q58816226 | ||
| Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells | Q58816342 | ||
| Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program | Q61669073 | ||
| Therapeutic targeting of a stem cell niche | Q61802299 | ||
| CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells | Q64374881 | ||
| Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 | ||
| CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group | Q73422585 | ||
| Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects | Q73919576 | ||
| Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment | Q73954935 | ||
| Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 | ||
| Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration | Q77626680 | ||
| Endothelial progenitor cells are mobilized after cardiac surgery | Q79674660 | ||
| Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke | Q80156994 | ||
| Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model | Q80300398 | ||
| Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential | Q80604936 | ||
| Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 | ||
| Hematopoietic stem cell mobilization | Q80798021 | ||
| Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease | Q81072687 | ||
| Endothelial progenitor cells during cerebrovascular disease | Q81089704 | ||
| Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells | Q81110853 | ||
| Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study | Q81963102 | ||
| The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier | Q83814322 | ||
| The mobilisation of mononuclear cells and endothelial progenitor cells after burn injury in a porcine model | Q84621929 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 2193432 | |
| P577 | publication date | 2017-08-16 | |
| P1433 | published in | Stem Cells International | Q26842114 |
| P1476 | title | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application | |
| P478 | volume | 2017 |
| Q95360330 | Angiotensin II Attenuates the Bioactivities of Human Endothelial Progenitor Cells via Downregulation of β2-Adrenergic Receptor |
| Q97883841 | Combined Transplantation of Adipose Tissue-Derived Stem Cells and Endothelial Progenitor Cells Improve Diabetic Erectile Dysfunction in a Rat Model |
| Q64237401 | Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular events |
| Q92794168 | Endothelial progenitor cells, potential biomarkers for diagnosis and prognosis of ischemic stroke: protocol for an observational case-control study |
| Q55618499 | Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke. |
| Q47554530 | Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review). |
| Q90659450 | Highlight article: The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer |
| Q55004553 | Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials. |
| Q95270721 | Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive Impairments |
| Q93062171 | Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid |
| Q42267329 | Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy |
| Q92715042 | Slit3 regulates migration of endothelial progenitor cells by activation of the RhoA/Rho kinase pathway |
Search more.